- US inspectors arrive in PwC, KPMG offices in Hong Kong to review Chinese companies’ audit records, sources say (scmp)
- The mighty dollar may be about to crack, says this strategist, who offers stocks to watch on either side. (marketwatch)
- China central bank cuts 14-day reverse repo rate, steps up cash injections (cnbc)
- Goldman Sachs Prefers the US Stock Market. Why Alibaba Is an Exception. (barrons)
- Bluebird Bio Stock Soars on FDA Approval of Gene Therapy for Rare Neurological Disease (barrons)
- AutoZone Stock Rises After Posting Strong Profits (barrons)
- Will GE HealthCare Stock Find a Home With Investors? (barrons)
- Back-to-work barometer falls short of measuring up to reality as offices fill up (nypost)
- Ralph Lauren Sees Faster Growth on Higher Prices, New Customers (bloomberg)
- China’s Factories Accelerate Robotics Push as Workforce Shrinks (wsj)
- Do Wages Drive Prices, or Vice Versa? The Answer Matters for Interest Rates (wsj)
- Economy Week Ahead: Federal Reserve and Other Central Banks in Focus (wsj)
- Are Biotech IPOs Coming Back? Some Investors Think So (wsj)
- Rising Bond Yields Change the Calculus for Stocks (wsj)
- Homebuilder sentiment tumbles for ninth consecutive month (foxbusiness)
- Xi and Modi ‘not standing with Putin’ over war in Ukraine, analysts say (ft)
- China Vanke spin-off seeks $780mn in Hong Kong’s biggest IPO this year (ft)
- Stanley Druckenmiller says the Fed is like a ‘reformed smoker,’ while Jeff Gundlach warns it’s driving the US into a dumpster. 6 market experts talk straight about rate hikes. (businessinsider)
- Alibaba sets up AI labs with two prestigious Chinese universities (scmp)
- Goldman unsure if Chinese stocks can rally before Communist Party congress (scmp)